Dr Rosi Hermann is Co-CEO of Leyton, an international innovation and funding consultancy. She brings over 10 years of experience in the acquisition of (international) R&D funding, especially in the food & beverage industry, biotechnology and health research. In addition to her PhD in Molecular Medicine at the Max Planck Institute of Biochemistry, she holds an MBA & Engineering degree. In 2022 she joined Leyton as Senior Scientific Consultant; since 2023 she is Co-Managing Director at Leyton Germany.